The medication works by mimicking naturally occurring incretin hormones that regulate blood glucose levels and appetite
Both tirzepatide and retatrutide activate GIPR, but tirzepatide is strictly a dual GIP/GLP-1 agonist while retatrutide additionally activates the glucagon receptor, classifying it as a triple agonist
Theyve long been used to help people with diabetes maintain a moderate weight
4.Need to antifreeze, long-term precipitation can occur
Examples may include micronutrient support, protein supplementation guidance, or appetite management tools, all integrated into the patients personalized plan through the Medvi patient portal Medvi Medication & Products Summary Table *Average weight loss figures based on clinical trial data for active pharmaceutical ingredients, not Medvi-specific outcomes
Vomiting happens in approximately 9% of users, typically only if you eat too much too quickly